Spironolactone
اسپیرونولاکتون
❤️ Cardiovascular SystemAldosterone antagonist (potassium-sparing diuretic)
Market / country: 🇺🇸 USA
Aldactone (US)
🧮 Dose calculator
Heart failure · Regimen source: FDA Spironolactone · 2.2
- • If potassium ≤5.0 and eGFR >50. If tolerated up to 50 mg; with hyperkalemia 25 mg every other day. eGFR 30–50: start every other day. FDA Spironolactone · 2.2FDA Spironolactone · 2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hyperkalemia; Addison's disease; concomitant eplerenone. FDA Spironolactone · 4
Formulations
- 25 mg tablet — tablet 🇺🇸 USA FDA Spironolactone · 3
- 50 mg tablet (scored) — tablet 🇺🇸 USA FDA Spironolactone · 3
- 100 mg tablet (scored) — tablet 🇺🇸 USA FDA Spironolactone · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Spironolactone · 8.1
“Risk Summary Based on mechanism of action and findings in animal studies, spironolactone may affect sex differentiation of the male during embryogenesis (see Data).”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Spironolactone · 8.2
“Risk Summary Spironolactone is not present in breastmilk; however, limited data from a lactating woman at 17 days postpartum reports the presence of the active metabolite, canrenone, in human breast milk in low amounts that are expected to be clinically inconsequential.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Spironolactone · 8.4
“Safety and effectiveness in pediatric patients have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Spironolactone · 8.5
“Because elderly patients are more likely to have decreased renal function, monitor renal function.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA202187
- DailyMed (FDA label)FDA Spironolactone
- MedlinePlus (NIH)Spironolactone
- WHO ATC/DDDC03DA01
- Darooyab (Iran)Spironolactone
🇮🇷 Registered in Iran Darooyab · G-1887/Spironolactone
Dosage forms with Iranian generic codes, per Darooyab.
- 02099 · SPIRONOLACTONE 100MG TAB · قرص اسپیرونولاکتون ۱۰۰ میلیگرم
- 01169 · SPIRONOLACTONE 25MG TAB · قرص اسپیرونولاکتون ۲۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Spironolactone · 3FDA Spironolactone · 2.2FDA Spironolactone · 2FDA Spironolactone · 2.3FDA Spironolactone · 2.5FDA Spironolactone · 8.4FDA Spironolactone · 4FDA Spironolactone · 8.1FDA Spironolactone · 8.2FDA Spironolactone · 8.5FDA Spironolactone · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1887/Spironolactone
- Clinical review⚠ Unverified